Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Opioid-use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Avery Road Treatment Center (ARTC), Rockville, Maryland, United States
Contact: Study coordinator (Praveena Machineni) · PMachineni@marylandtreatment.org · 240-739-0626
Contact: Study coordinator (Lauren Rudin) · LRudin@marylandtreatment.org · 240-739-0601
Contact: Principal Investigator (Kevin Wenzel, PhD)
Stars/Nyspi, New York, New York, United States

Study leads

Adam Bisaga, MD
Principal Investigator
New York State Psychiatric Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Smartphones for Opiate Addiction Recovery

Opioid-use Disorder

Abroad (travel likely)RecruitingPHASE3

Piscataway, United States · New York, United States

Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes

Opioid-use Disorder · Opioid Use, Unspecified · Buprenorphine Dependence

Abroad (travel likely)Recruiting

Pittsburgh, United States

Reducing Opioid Mortality in Illinois

Opioid Use · Opioid-use Disorder

Abroad (travel likely)Recruiting

Chicago, United States · Murphysboro, United States

Ketamine Assisted Psychotherapy for Opioid Use Disorder

Opioid-use Disorder

Abroad (travel likely)RecruitingPHASE1, PHASE2

Salt Lake City, United States